CRISPRi: a way to integrate iPSC-derived neuronal models.

Area of Science:

• Neuroscience
• Genetics
• Stem Cell Biology

Background:

• Neurodegenerative diseases involve complex genetic factors affecting various brain cells.
• Understanding gene roles and variant effects is crucial for developing effective treatments.
• Patient-derived induced pluripotent stem cells (iPSCs) offer a model system preserving disease-specific genetic mutations.

Purpose of the Study:

• To review the application of CRISPR interference (CRISPRi) in iPSC-derived neuronal models for neurodegenerative disease research.
• To highlight CRISPRi's utility in modeling disease-associated variants and identifying genetic modifiers.
• To explore future opportunities in disease modeling, risk modifier identification, and drug discovery.

Main Methods:

• Utilizing CRISPR interference (CRISPRi) for gene perturbation in iPSC-derived neuronal models.
• Employing techniques like fluorescence-activated cell sorting (FACS)-based screens for high-throughput analysis.
• Generating and characterizing iPSC-derived neuronal and glial cell types relevant to neurodegeneration.

Main Results:

• CRISPRi enables precise modeling of disease-associated genetic variants in patient-derived cells.
• CRISPRi facilitates the identification of genes that modify neurodegenerative disease phenotypes.
• CRISPRi-based screens can uncover novel therapeutic targets and drug candidates.

Conclusions:

• CRISPRi in iPSC-derived neuronal models is a powerful tool for dissecting neurodegenerative disease mechanisms.
• This approach accelerates the identification of genetic risk modifiers and potential therapeutic targets.
• Future applications promise significant advancements in understanding and treating neurodegenerative disorders.